Literature DB >> 35968074

A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort.

Tanita Suttichaimongkol1, Chitchai Rattananukrom1, Arthit Wongsaensook1, Wattana Sukeepaisarnjaroen1, Kittisak Sawanyawisuth1.   

Abstract

Introduction: Hepatitis C virus (HCV) infection is an infection that may lead to cirrhosis and hepatocellular carcinoma. Most patients with HCV infection are asymptomatic. The previous study conducted in age group of 30-64 years and in two provinces. Additionally, most surveillance studies conducted in a point period; not longitudinally. This study aimed to evaluate HCV infection rate in all age groups in the northeastern, Thailand in a longitudinal fashion.
Methods: This was a surveillance study conducted in 20 provinces of northeastern, Thailand. The study period was between July 2010 and November 2019. During the surveillance, demographic data of participants were collected. HCV screening test was performed in each participant by using a rapid point-of-care assay. Rates of HCV infection in each province and in overall were calculated.
Results: During the surveillance period, there were 31,855 subjects who participated the project. Of those, 1,285 subjects (4.037%) were tested positive for HCV infection (Tab. I). The HCV infection rate was highest in 2011 (8.98%): ranges 1.28 to 9.59%. The age group of over 50 years had 690 subjects with HCV infection (5.45%) out of 12,660 subjected tested in this age group. There was significant different among age groups (p < 0.001) and difference of age over 30 years and sex (p 0.043). Conclusions: This longitudinal surveillance showed that HCV infection rates in northeastern, Thailand were varied across the provinces with the highest rate of 9.59%. The HCV infection should be aware in male with age over 30 years. ©2022 Pacini Editore SRL, Pisa, Italy.

Entities:  

Keywords:  Age; Hepatitis C virus; Sex

Mesh:

Year:  2022        PMID: 35968074      PMCID: PMC9351421          DOI: 10.15167/2421-4248/jpmh2022.63.2.2120

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


Introduction

Hepatitis C virus (HCV) infection is an infection that may lead to cirrhosis and hepatocellular carcinoma. Its global prevalence was approximately 1.6% or 115 million persons [1]. HCV infection is much more common in adults compare with children (90%:10%) or 104 vs 11 million patients [1]. The prevalence rate of HCV infection is varied among countries with the highest rate in Egypt at 14.70%. A serological surveillance in 310 Belgian forest workers showed seroprevalence of Lyme disease which determined the population at risk for those asymptomatic [2]. Patients with HCV infection are mostly asymptomatic. Therefore, community surveillance may be helpful to identify infected patients. In Thailand, endemic areas for HCV infection, found the prevalence of HCV infection was 6.9% reported in 2020 and previously reported to be 15.5% in 2017 [3, 4]. The previous study conducted in age group of 30-64 years and in two provinces [5]. Additionally, most surveillance studies conducted in a point period; not longitudinally. This study aimed to evaluate HCV infection rate in all age groups in the northeastern, Thailand in a longitudinal fashion.

Methods

This was a surveillance study conducted in 20 provinces of northeastern, Thailand. The study period was between July 2010 and November 2019. The surveillance was conducted in multiple areas in each province on a random basis. Each surveillance comprised of HCV screening and educational activities regarding HCV awareness by multidisciplinary health care team. The concept of awareness of HCV infection according to the world hepatitis alliance was implemented. During the surveillance, demographic data of participants were collected. HCV screening test was performed in each participant by using a rapid point-of-care assay (One Step Rapid Test for HCV; HEALGEN, TX77401, USA). This rapid test has sensitivity and specificity for HCV infection of 98.1% and 98.9%, respectively. Those with test positive for HCV infection were referred for proper treatment. Rates of HCV infection in each province and in overall were calculated. Descriptive statistics were used to compute the differences by age group and sex. A p-value of less than 0.05 considered statistical significance. The study protocol was approved by the ethic committee in human research, Khon Kaen University, Thailand (HE621134). An informed consent was not obtained due to retrospective data collection.

Results

During the surveillance period, there were 31,855 subjects who participated the project. Of those, 1,285 subjects (4.037%) were tested positive for HCV infection (Tab. I). The HCV infection rate was highest in 2011 (8.98%). Among 20 provinces, Udonthani and Khon Kaen province were the top two provinces with the highest HCV infection rate at 9.59%, and 7.86% (Tab. II). The HCV infection ranged from 1.28 to 9.59%. The age group of over 50 years had 690 subjects with HCV infection (5.45%) out of 12,660 subjected tested in this age group (Tab. III). There was significant different among age groups (p < 0.001) and difference of age over 30 years and sex (p 0.043).
Tab. I.

Details of hepatitis C virus (HCV) infection by the HCV surveillance project in northeastern, Thailand.

YearTotal tested for HCV (n)Test positive for HCV (n)Test positive for HCV (%)
2010419245.73
2011846768.98
20122,9641625.46
20134,7612535.31
20145,076881.73
20153,139662.10
20164,3142796.46
20174,8112555.30
20182,948531.79
20192,577291.12
Total31,8551,2854.03
Tab. II.

Details of hepatitis C virus (HCV) infection by the HCV surveillance project in northeastern, Thailand categorized by province.

ProvincesYear testedTotal tested for HCV (n)Test positive for HCV (n)Test positive for HCV (%)
Beung kan2017603256.51
Khon Kaen2010-20194,9133867.86
Sakon Nakhon2012-2014, 2017981262.65
Si sa ket2014-20171,727643.70
Burirum2012-2016, 20181,647583.52
Mukdaharn2015, 2017462102.16
Amnat Chareon2017261134.98
Maha Sarakam2013, 2015-20171,459563.84
Udonthani2011-20171,3651319.59
Nong khai2013-20194,3321182.72
Nakorn Panom2015, 2017766222.87
Ubon Ratchathani2013, 2014 2018975151.54
Nakorn Ratchasima2012, 2014, 2016, 20191,571432.74
Chaiyaphum2013-2014, 2016, 20171,906743.88
Surin2011-20193,275611.86
Kalasin2013-2014, 2016-20192,1511145.29
Loei2014, 201870191.28
Roi-et2012-2014, 20182,069472.27
Yasothon201830472.30
Nong bua lumphu2016, 201938761.55
Total31,8551,2854.03
Tab. III.

Details of hepatitis B virus (HCV) infection by the HCV surveillance project in northeastern, Thailand categorized by age group and sex.

Age groupTotal tested (n)Test positive for HCV, n (%)Test positive for HCV, n (%)
MaleFemale
0-10210000
11-201,0531 (0.9)1 (0.09)0 (0)
21-303,91925 (0.65)17 (0.43)8 (0.2)
31-404,247159 (3.74)135 (3.18)24 (0.56)
41-509,766410 (4.19)335 (3.43)75 (0.77)
> 50-6012,660690 (5.45)607 (4.79)83 (0.66)
Total31,8551,285 (4.03)1,095 (3.44)190 (0.60)

Discussion

As previously reported, estimation of disease is not enough for people who inject drugs [6]. HCV infection is estimated to be 52.3% of people with inject drug. This surveillance showed that average HCV infection rate in this 10-year cohort among 20 provinces. The highest rate of HCV infection was higher than the recent survey in 2020 (9.59% vs 6.9%) [3]. This study found similar findings with the previous study on HCV infection rate among age groups [4]. The seroprevalence was low at age group of under 35-40 years: ranges 0.0-3.5%. In this study, we found that the HCV infection rate was dramatically increasing from 0.0%-0.90% in age group below 30 years to 3.74% in age group of 31-40 years (Tab. III) which was also statistically significant (p < 0.001). However, this rising rate was not shown in both groups: only male sex (p = 0.043). The female group had quite steady rate from 0.0% to 0.77% (Tab. III). These findings may be explained from higher rate of people with inject drug in male patients. A study from northern, Thailand found that 81.8% out of 164 people with inject drug were male and 57.3% of subjects had first intravenous drug use at age below 24 years [7]. These finding may also explain why the HCV infection was significantly increased after age group of 30 years. This study showed 10-year surveillance in almost provinces in the northeastern, Thailand. However, there are some limitations. First, participants in the project were those participated the world hepatitis alliance in that province. The total population tested for HCV infection was quite large at 31.855 persons though. And, the HCV test was the point of care test but it has a good sensitivity and specificity [8]. Some related conditions were not studied [9-16]. Finally, HCV genotypes were not evaluated.

Conclusions

This longitudinal surveillance showed that HCV infection rates in northeastern, Thailand were varied across the provinces with the highest rate of 9.59%. The HCV infection should be aware in male with age over 30 years.

Acknowledgements

None. Details of hepatitis C virus (HCV) infection by the HCV surveillance project in northeastern, Thailand. Details of hepatitis C virus (HCV) infection by the HCV surveillance project in northeastern, Thailand categorized by province. Details of hepatitis B virus (HCV) infection by the HCV surveillance project in northeastern, Thailand categorized by age group and sex.
  14 in total

1.  Sleep disturbances in hepatitis C patients undergoing treatment: minisleep questionnaire as a screening tool.

Authors:  E Cordeiro Vitor Martins; M Costa Silva; J A Mesquita Martins Seabra De Oliveira; R Pereira; T Mascarenhas Godinho Reis
Journal:  Minerva Gastroenterol Dietol       Date:  2015-09

2.  Estimates are not enough: scaling-up interventions to improve the health of people who inject drugs.

Authors:  Maria Prins; Julie Bruneau
Journal:  Lancet Glob Health       Date:  2017-12       Impact factor: 26.763

Review 3.  Global epidemiology and genotype distribution of the hepatitis C virus infection.

Authors:  Erin Gower; Chris Estes; Sarah Blach; Kathryn Razavi-Shearer; Homie Razavi
Journal:  J Hepatol       Date:  2014-07-30       Impact factor: 25.083

4.  Obstructive sleep apnea in patients with diabetes less than 40 years of age.

Authors:  Benjawan Soontornrungsun; Sittichai Khamsai; Bundit Sawunyavisuth; Panita Limpawattana; Jarin Chindaprasirt; Vichai Senthong; Verajit Chotmongkol; Kittisak Sawanyawisuth
Journal:  Diabetes Metab Syndr       Date:  2020-09-10

5.  Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.

Authors:  Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Nipaporn Siripon; Nawarat Posuwan; Chompoonut Auphimai; Sirapa Klinfueng; Napha Thaneskongtong; Viboonsak Vuthitanachot; Supapith Saiyatha; Chaiwat Thongmai; Sarawut Suwanpatoomlerd; Saowakon Sochoo; Natnada Pongsuwan; Kittiyod Poovorawan; Pisit Tangkijvanich; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

6.  Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.

Authors:  Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Nipaporn Siripon; Nawarat Posuwan; Chompoonut Auphimai; Sirapa Klinfueng; Napha Thanetkongtong; Viboonsak Vuthitanachot; Supapith Saiyatha; Chaiwat Thongmai; Saowakon Sochoo; Panthip Sukthong; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Efficacy of Generic Atorvastatin in a Real-World Setting.

Authors:  Panisa Manasirisuk; Nanthaphan Chainirun; Somsak Tiamkao; Sunee Lertsinudom; Kutcharin Phunikhom; Bundit Sawunyavisuth; Kittisak Sawanyawisuth
Journal:  Clin Pharmacol       Date:  2021-03-05

8.  Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data.

Authors:  Arvind Tomar; Ankit Bhardwaj; Ashok Choudhary; Debajyoti Bhattacharyya
Journal:  J Family Med Prim Care       Date:  2021-08-27

9.  Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.

Authors:  Myrtille Prouté; Sophie Le Coeur; Métrey H Tiv; Timothée Dub; Parinya Jongpaijitsakul; Anantika Ratnamhin; Chaisiri Angkurawaranon; Apinun Aramrattana; Marc Lallemant
Journal:  BMC Public Health       Date:  2020-09-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.